Ferric carboxymaltose in patients with heart failure and iron deficiency. (otvara se novi prozor)

Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P; FAIR-HF Trial Investigators.

Izvor‎: N Engl J Med 2009;361(25):2436-48.

Indeks‎: PubMed 19920054

DOI‎: 10.1056/NEJMoa0908355

https://www.ncbi.nlm.nih.gov/pubmed/19920054 (otvara se novi prozor)

Successful repair of a giant abdominal aortoiliac aneurysm in a Jehovah's Witness. (otvara se novi prozor)

Bayam L, Tait WF, Macartney ID.

Izvor‎: Vasc Endovascular Surg 2007;41(5):460-2.

Indeks‎: PubMed 17942864

DOI‎: 10.1177/1538574407303172

https://www.ncbi.nlm.nih.gov/pubmed/17942864 (otvara se novi prozor)

Blood loss and transfusion rates associated with transcatheter aortic valve replacement: recommendations for patients who refuse blood transfusion. (otvara se novi prozor)

Binder RK, Barbanti M, Ye J, Toggweiler S, Tan J, Freeman M, Cheung A, Wood DA, Webb JG.

Izvor‎: Catheter Cardiovasc Interv 2014;83(6):E221-6.

Indeks‎: PubMed 24402965

DOI‎: 10.1002/ccd.25389

https://www.ncbi.nlm.nih.gov/pubmed/24402965 (otvara se novi prozor)

Impact of preoperative erythropoietin on allogeneic blood transfusions in surgical patients: results from a systematic review and meta-analysis. (otvara se novi prozor)

Cho BC, Serini J, Zorrilla-Vaca A, Scott MJ, Gehrie EA, Frank SM, Grant MC

Izvor‎: Anesth Analg 2019;128(5):981-92.

Indeks‎: PubMed 30649068

DOI‎: 10.1213/ANE.0000000000004005

https://www.ncbi.nlm.nih.gov/pubmed/30649068 (otvara se novi prozor)

Epoetin dosing for blood conservation in Jehovah's Witness patients undergoing cardiac surgery—a systematic review. (otvara se novi prozor)

Chua D, Amadio A, San C.

Izvor‎: Can J Cardiol 2014;30(Suppl):S234.

DOI‎: 10.1016/j.cjca.2014.07.398

http://www.onlinecjc.ca/article/S0828-282X(14)00876-9/abstract (otvara se novi prozor)

Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. (otvara se novi prozor)

Cladellas M, Farré N, Comín-Colet J, Gómez M, Meroño O, Bosch MA, Vila J, Molera R, Segovia A, Bruguera J.

Izvor‎: Am J Cardiol 2012;110(7):1021-6.

Indeks‎: PubMed 22771376

DOI‎: 10.1016/j.amjcard.2012.05.036

https://www.ncbi.nlm.nih.gov/pubmed/22771376 (otvara se novi prozor)

Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. (otvara se novi prozor)

Filippatos G, Farmakis D, Colet JC, Dickstein K, Lüscher TF, Willenheimer R, Parissis J, Gaudesius G, Mori C, von Eisenhart Rothe B, Greenlaw N, Ford I, Ponikowski P, Anker SD.

Izvor‎: Eur J Heart Fail 2013;15(11):1267-76.

Indeks‎: PubMed 23787722

DOI‎: 10.1093/eurjhf/hft099

https://www.ncbi.nlm.nih.gov/pubmed/23787722 (otvara se novi prozor)

Current status of pharmacologic therapies in patient blood management. (otvara se novi prozor)

Goodnough LT, Shander A.

Izvor‎: Anesth Analg 2013;116(1):15-34.

Indeks‎: PubMed 23223098

DOI‎: 10.1213/ANE.0b013e318273f4ae

https://www.ncbi.nlm.nih.gov/pubmed/23223098 (otvara se novi prozor)

Intraoperative anemia and single red blood cell transfusion during cardiac surgery: an assessment of postoperative outcome including patients refusing blood transfusion. (otvara se novi prozor)

Hogervorst EK, Rosseel PM, van de Watering LM, Brand A, Bentala M, van der Bom JG, van der Meer NJ.

Izvor‎: J Cardiothorac Vasc Anesth 2016;30(2):363-72.

Indeks‎: PubMed 26809765

DOI‎: 10.1053/j.jvca.2015.10.021

https://www.ncbi.nlm.nih.gov/pubmed/26809765 (otvara se novi prozor)

The influence of baseline hemoglobin concentration on tolerance of anemia in cardiac surgery. (otvara se novi prozor)

Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, van Rensburg A, Beattie WS.

Izvor‎: Transfusion 2008;48(4):666-72.

Indeks‎: PubMed 18194382

DOI‎: 10.1111/j.1537-2995.2007.01590.x

https://www.ncbi.nlm.nih.gov/pubmed/18194382 (otvara se novi prozor)

Randomised open-label trial comparing intravenous iron and an erythropoiesis-stimulating agent versus oral iron to treat preoperative anaemia in cardiac surgery (INITIATE trial). (otvara se novi prozor)

Kong R, Hutchinson N, Hill A, Ingoldby F, Skipper N, Jones C, Bremner S, Bruce C, Wright J, Lewis M, Newman S, Chevassut T, Hildick-Smith D

Izvor‎: Br J Anaesth. 2022;128(5):796-805.

Indeks‎: PubMed 35256150

DOI‎: 10.1016/j.bja.2022.01.034

https://pubmed.ncbi.nlm.nih.gov/35256150/ (otvara se novi prozor)

Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. (otvara se novi prozor)

Lin DM, Lin ES, Tran MH.

Izvor‎: Transfus Med Rev 2013;27(4):221-34.

Indeks‎: PubMed 24135037

DOI‎: 10.1016/j.tmrv.2013.09.001

https://www.ncbi.nlm.nih.gov/pubmed/24135037 (otvara se novi prozor)

The least of 3 evils: exposure to red blood cell transfusion, anemia, or both? (otvara se novi prozor)

Loor G, Rajeswaran J, Li L, Sabik JF 3rd, Blackstone EH, McCrae KR, Koch CG.

Izvor‎: J Thorac Cardiovasc Surg 2013;146(6):1480-7.e6.

Indeks‎: PubMed 23998782

DOI‎: 10.1016/j.jtcvs.2013.06.033

https://www.ncbi.nlm.nih.gov/pubmed/23998782 (otvara se novi prozor)

Jehovah's Witnesses and cardiac surgery: a single institution's experience. (otvara se novi prozor)

McCartney S, Guinn N, Roberson R, Broomer B, White W, Hill S.

Izvor‎: Transfusion 2014;54(10 Pt 2):2745-52.

Indeks‎: PubMed 24809815

DOI‎: 10.1111/trf.12696

https://www.ncbi.nlm.nih.gov/pubmed/24809815 (otvara se novi prozor)

Determining optimal treatment to correct preoperative anemia and reduce perioperative allogeneic blood transfusions in cardiac surgery: a retrospective cohort study. (otvara se novi prozor)

Peel JK, Trudeau J, Tano R, Jadunandan S, Callum J, Moussa F, Lin Y

Izvor‎: J Cardiothorac Vasc Anesth 2021;35(9):2631-9.

Indeks‎: PubMed 33483268

DOI‎: 10.1053/j.jvca.2020.12.044

https://pubmed.ncbi.nlm.nih.gov/33483268/ (otvara se novi prozor)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (otvara se novi prozor)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Izvor‎: Surg Infect (Larchmt) 2009;10(1):9-19.

Indeks‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (otvara se novi prozor)

Efficacy of quadruple treatment on different types of pre-operative anaemia: secondary analysis of a randomised controlled trial. (otvara se novi prozor)

Rössler J, Hegemann I, Schoenrath F, Seifert B, Kaserer A, Spahn GH, Falk V, Spahn DR

Izvor‎: Anaesthesia 2020;75(8):1039-49.

Indeks‎: PubMed 32342498

DOI‎: 10.1111/anae.15062

https://www.ncbi.nlm.nih.gov/pubmed/32342498 (otvara se novi prozor)

Preoperative erythropoietin and blood conservation management for thoracoabdominal aneurysm repair in a Jehovah's Witness. (otvara se novi prozor)

Sarac TP, Clifford C, Waters J, Clair DG, Ouriel K.

Izvor‎: J Vasc Surg 2003;37(2):453-5.

Indeks‎: PubMed 12563221

DOI‎: 10.1067/mva.2003.73

https://www.ncbi.nlm.nih.gov/pubmed/12563221 (otvara se novi prozor)

Intravenous iron in heart failure: beyond targeting anemia. (otvara se novi prozor)

Silverberg DS, Iaina A, Schwartz D, Wexler D.

Izvor‎: Curr Heart Fail Rep 2011;8(1):14-21.

Indeks‎: PubMed 21057903

DOI‎: 10.1007/s11897-010-0034-4

https://www.ncbi.nlm.nih.gov/pubmed/21057903 (otvara se novi prozor)

Cardiovascular surgery in Jehovah's Witness patients: the role of preoperative optimization. (otvara se novi prozor)

Tanaka A, Ota T, Uriel N, Asfaw Z, Onsager D, Lonchyna VA, Jeevanandam V.

Izvor‎: J Thorac Cardiovasc Surg 2015;150(4):976-83.e1-3.

Indeks‎: PubMed 26211405

DOI‎: 10.1016/j.jtcvs.2015.06.059

https://www.ncbi.nlm.nih.gov/pubmed/26211405 (otvara se novi prozor)

Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. (otvara se novi prozor)

Usmanov RI, Zueva EB, Silverberg DS, Shaked M.

Izvor‎: J Nephrol 2008;21(2):236-42.

Indeks‎: PubMed 18446719

https://www.ncbi.nlm.nih.gov/pubmed/18446719 (otvara se novi prozor)

Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. (otvara se novi prozor)

Weltert L, D'Alessandro S, Nardella S, Girola F, Bellisario A, Maselli D, De Paulis R.

Izvor‎: J Thorac Cardiovasc Surg 2010;139(3):621-7.

Indeks‎: PubMed 20042202

DOI‎: 10.1016/j.jtcvs.2009.10.012

https://www.ncbi.nlm.nih.gov/pubmed/20042202 (otvara se novi prozor)

A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. (otvara se novi prozor)

Weltert L, Rondinelli B, Bello R, Falco M, Bellisario A, Maselli D, Turani F, De Paulis R, Pierelli L.

Izvor‎: Transfusion 2015;55(7):1644-54.

Indeks‎: PubMed 25702777

DOI‎: 10.1111/trf.13027

https://www.ncbi.nlm.nih.gov/pubmed/25702777 (otvara se novi prozor)

Blood conservation strategies can be applied safely to high-risk complex aortic surgery. (otvara se novi prozor)

Yaffee DW, DeAnda A, Ngai JY, Ursomanno PA, Rabinovich AE, Ward AF, Galloway AC, Grossi EA.

Izvor‎: J Cardiothorac Vasc Anesth 2015;29(3):703-9.

Indeks‎: PubMed 25847415

DOI‎: 10.1053/j.jvca.2014.10.022

https://www.ncbi.nlm.nih.gov/pubmed/25847415 (otvara se novi prozor)

Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. (otvara se novi prozor)

Yoo YC, Shim JK, Kim JC, Jo YY, Lee JH, Kwak YL.

Izvor‎: Anesthesiology 2011;115(5):929-37.

Indeks‎: PubMed 22027622

DOI‎: 10.1097/ALN.0b013e318232004b

https://www.ncbi.nlm.nih.gov/pubmed/22027622 (otvara se novi prozor)